4.6 Article

Morbillivirus V Proteins Exhibit Multiple Mechanisms to Block Type 1 and Type 2 Interferon Signalling Pathways

期刊

PLOS ONE
卷 8, 期 2, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0057063

关键词

-

资金

  1. Pirbright Institute
  2. United Kingdom Biotechnology and Biological Sciences Research Council
  3. United Kingdom Department for International Development
  4. Biotechnology and Biological Sciences Research Council [BBS/E/I/00001368, BBS/E/I/00001719, BBS/E/I/00001433] Funding Source: researchfish
  5. BBSRC [BBS/E/I/00001719, BBS/E/I/00001433, BBS/E/I/00001368] Funding Source: UKRI

向作者/读者索取更多资源

Morbilliviruses form a closely related group of pathogenic viruses which encode three non-structural proteins V, W and C in their P gene. Previous studies with rinderpest virus (RPV) and measles virus (MeV) have demonstrated that these nonstructural proteins play a crucial role in blocking type I (IFN alpha/beta) and type II (IFN gamma) interferon action, and various mechanisms have been proposed for these effects. We have directly compared four important morbilliviruses, rinderpest (RPV), measles virus (MeV), peste des petits ruminants virus (PPRV) and canine distemper virus (CDV). These viruses and their V proteins could all block type I IFN action. However, the viruses and their V proteins had varying abilities to block type II IFN action. The ability to block type II IFN-induced gene transcription correlated with co-precipitation of STAT1 with the respective V protein, but there was no correlation between co-precipitation of either STAT1 or STAT2 and the abilities of the V proteins to block type I IFN-induced gene transcription or the creation of the antiviral state. Further study revealed that the V proteins of RPV, MeV, PPRV and CDV could all interfere with phosphorylation of the interferon-receptor-associated kinase Tyk2, and the V protein of highly virulent RPV could also block the phosphorylation of another such kinase, Jak1. Co-precipitation studies showed that morbillivirus V proteins all form a complex containing Tyk2 and Jak1. This study highlights the ability of morbillivirus V proteins to target multiple components of the IFN signalling pathways to control both type I and type II IFN action.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping

Naif Khalaf Alharbi, Senthil K. Chinnakannan, Sarah C. Gilbert, Simon J. Draper

PLOS ONE (2015)

Meeting Abstract Gastroenterology & Hepatology

THE GENERATION OF AN IMMUNOGENIC SECOND-GENERATION CONSERVED SEGMENT HCV T CELLVACCINE TO TARGET MULTIPLE HCV GENOTYPES

A. Von Delft, T. Donnison, S. Chinnakannan, J. Lourenco, C. Hutchings, A. Brown, P. Klenerman, E. Barnes

JOURNAL OF HEPATOLOGY (2016)

Article Immunology

Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter

Naif Khalaf Alharbi, Alexandra J. Spencer, Ahmed M. Salman, Claire M. Tully, Senthil K. Chinnakannan, Teresa Lambe, Yuko Yamaguchi, Susan J. Morris, Toritse Orubu, Simon J. Draper, Adrian V. S. Hill, Sarah C. Gilbert

VACCINE (2016)

Article Immunology

Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge

Claire M. Tully, Senthil Chinnakannan, Caitlin E. Mullarkey, Marta Ulaszewska, Francesca Ferrara, Nigel Temperton, Sarah C. Gilbert, Teresa Lambe

JOURNAL OF IMMUNOLOGY (2017)

Meeting Abstract Gastroenterology & Hepatology

A pan-genotype HCV T cell vaccine, in a simian adenovirus vector, to target T cell epitopes conserved across multiple HCV genotypes

T. Donnison, A. von Delft, S. K. Chinnakannan, J. Lourenco, C. Hutchings, A. Brown, P. Klenerman, E. Barnes

JOURNAL OF HEPATOLOGY (2018)

Meeting Abstract Gastroenterology & Hepatology

A novel chimpanzee adenoviral vectored HBV vaccine, encoding multiple HBV antigens with a shark invariant chain adjuvant, for use in HBV immunotherapy

S. K. Chinnakannan, T. Cargill, T. Donnison, A. Ansari, M. Maini, T. Evans, E. Barnes

JOURNAL OF HEPATOLOGY (2018)

Article Immunology

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes

Annette von Delft, Timothy A. Donnison, Jose Lourenco, Claire Hutchings, Caitlin E. Mullarkey, Anthony Brown, Oliver G. Pybus, Paul Klenerman, Senthil Chinnakannan, Eleanor Barnes

VACCINE (2018)

Article Biotechnology & Applied Microbiology

Different functions of the common P/V/W and V-specific domains of rinderpest virus V protein in blocking IFN signalling

Senthil K. Chinnakannan, Barbara Holzer, Beatriz Sanz Bernardo, Sambit K. Nanda, Michael D. Baron

JOURNAL OF GENERAL VIROLOGY (2014)

Article Immunology

Divergent memory responses driven by adenoviral vectors are impacted by epitope competition

Julia M. Colston, Claire Hutchings, Senthil Chinnakannan, Andrew Highton, Christian Perez-Shibayama, Burkhard Ludewig, Paul Klenerman

EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

Meeting Abstract Gastroenterology & Hepatology

Prime-boost vaccination strategies using chimpanzee-adeno and MVA viral vectored vaccines encoding multiple HBV antigens (CPmutS) and class II invariant chain molecular adjuvants induces robust T-cell and anti-HBs antibody response in mice

Tamsin Cargill, Timothy Donnison, Azim Ansari, Mala Maini, Tom Evans, Eleanor Barnes, Senthil Kumar Chinnakannan

JOURNAL OF HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus

Erwan Atcheson, Wenqin Li, Carly M. Bliss, Senthil Chinnakannan, Kathrin Heim, Hannah Sharpe, Claire Hutchings, Isabelle Dietrich, Dung Nguyen, Amit Kapoor, Michael A. Jarvis, Paul Klenerman, Eleanor Barnes, Peter Simmonds

HEPATOLOGY (2020)

Article Immunology

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV

Senthil K. Chinnakannan, Tamsin N. Cargill, Timothy A. Donnison, M. Azim Ansari, Sarah Sebastian, Lian Ni Lee, Claire Hutchings, Paul Klenerman, Mala K. Maini, Tom Evans, Eleanor Barnes

VACCINES (2020)

Article Immunology

Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes

Timothy Donnison, Annette von Delft, Anthony Brown, Leo Swadling, Claire Hutchings, Tomas Hanke, Senthil Chinnakannan, Eleanor Barnes

VACCINE (2020)

Article Multidisciplinary Sciences

MAIT cell activation augments adenovirus vector vaccine immunogenicity

Nicholas M. Provine, Ali Amini, Lucy C. Garner, Alexandra J. Spencer, Christina Dold, Claire Hutchings, Laura Silva Reyes, Michael E. B. FitzPatrick, Senthil Chinnakannan, Blanche Oguti, Meriel Raymond, Marta Ulaszewska, Fulvia Troise, Hannah Sharpe, Sophie B. Morgan, Timothy S. C. Hinks, Teresa Lambe, Stefania Capone, Antonella Folgori, Eleanor Barnes, Christine S. Rollier, Andrew J. Pollard, Paul Klenerman

Summary: MAIT cells play a crucial role in vaccine immunogenicity, requiring the synergistic activation of IFN, cytokines, and signaling pathways. The study indicates that MAIT cells can enhance vaccine-induced T cell responses, with implications for vaccine design.

SCIENCE (2021)

Article Gastroenterology & Hepatology

A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice

Timothy Donnison, Joey McGregor, Senthil Chinnakannan, Claire Hutchings, Rob J. Center, Pantelis Poumbourios, Paul Klenerman, Heidi E. Drummer, Eleanor Barnes

Summary: This study aims to develop a vaccine that can generate both viral-specific B-cell and T-cell responses concurrently to target multiple HCV genotypes.

HEPATOLOGY (2022)

暂无数据